Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i>ATM, CTLA4, MNDA</i>, and<i>HEM1</i>in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia

15 Sept 2007

Abstract excerpt

PURPOSE: In B-cell chronic lymphocytic leukemia (CLL), high CD38 expression has been associated with unfavorable clinical course, advanced disease, resistance to therapy, shorter time to first treatment, and shorter survival. However, the genes associated with CLL patient subgroups with high and low CD38 expression and their potential role in disease progression is not known. EXPERIMENTAL DESIGN: To identify the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium signaling and nucleotide metabolism
Share to Chronic Lymphocytic Leukemia Research
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17875758
DOI: 10.1158/1078-0432.ccr-07-0283

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i>ATM, CTLA4, MNDA</i>, and<i>HEM1</i>in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic LeukemiaPMID 17875758Read ↗

CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL.Semantic proximity Read ↗

Role of CD38 Expression in Diagnosis and Pathogenesis of Chronic Lymphocytic Leukemia and Its Potential as Therapeutic TargetSemantic proximity Read ↗

Immunoglobulin V(H) genes and CD38 expression analysis in B-cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Highly purified CD38+ and CD38− sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal originSemantic proximity Read ↗

CD38 and chronic lymphocytic leukemia: a decade laterSemantic proximity Read ↗

Large-Scale Analysis of DNA Methylation In Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system.Semantic proximity Read ↗

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.Semantic proximity Read ↗

Absence of CD38 expression in mantle cell lymphoma correlates with distinct pathological and genetic features.Semantic proximity Read ↗

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia.Semantic proximity Read ↗

CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemiaSemantic proximity Read ↗

ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.